HK Stock MarketDetailed Quotes

09995 REMEGEN

Watchlist
  • 23.400
  • +1.150+5.17%
Not Open Mar 28 16:08 CST
12.74BMarket Cap-8.03P/E (TTM)

REMEGEN Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
Turnover
58.92%1.71B
57.10%1.21B
76.50%739.66M
96.41%330.43M
40.16%1.08B
35.08%769.47M
20.15%419.07M
12.06%168.24M
-46.08%767.78M
397.47%569.64M
Operating income
58.92%1.71B
57.10%1.21B
76.50%739.66M
96.41%330.43M
40.16%1.08B
35.08%769.47M
20.15%419.07M
12.06%168.24M
-46.08%767.78M
397.47%569.64M
Cost of sales
-35.42%-342.8M
----
-64.89%-169.27M
----
6.22%-253.14M
----
38.72%-102.66M
----
-301.92%-269.94M
----
Operating expenses
-35.42%-342.8M
-37.65%-244.74M
-64.89%-169.27M
-196.17%-74.36M
6.22%-253.14M
20.47%-177.8M
38.72%-102.66M
74.25%-25.11M
-301.92%-269.94M
-2,079.96%-223.57M
Gross profit
66.14%1.37B
62.95%964.13M
80.26%570.39M
78.91%256.08M
65.31%822.99M
70.97%591.67M
74.55%316.42M
171.98%143.13M
-63.31%497.84M
231.95%346.06M
Selling expenses
-22.39%-948.76M
-15.36%-622.7M
-11.28%-389.67M
-18.81%-187.5M
-75.90%-775.19M
-94.41%-539.79M
-133.51%-350.17M
-95.36%-157.82M
-67.59%-440.7M
-115.68%-277.66M
Administrative expenses
-5.93%-332.28M
3.39%-234.62M
7.94%-155.22M
5.70%-74.26M
-15.09%-313.67M
-51.17%-242.87M
-57.70%-168.61M
-60.52%-78.75M
-23.97%-272.54M
-0.86%-160.66M
Research and development expenses
-17.87%-1.54B
-34.43%-1.15B
-49.18%-806.23M
-32.62%-331.18M
-33.01%-1.31B
-29.50%-857.98M
-20.19%-540.45M
-14.46%-249.72M
-38.13%-982.08M
-26.29%-662.54M
Profit from asset sales
----
--88.36K
----
----
----
----
----
----
----
-3.02%15.5K
Revaluation surplus
----
-86.10%718.29K
----
-101.81%-49.46K
----
-55.15%5.17M
----
--2.73M
----
--11.53M
-Changes in the fair value of other assets
----
-86.10%718.29K
----
-101.81%-49.46K
----
-55.15%5.17M
----
--2.73M
----
--11.53M
Impairment and provision
1.67%-11.09M
-5.77%-15.78M
7.30%-3.81M
-346.42%-4.66M
-1.33%-11.28M
-63.53%-14.92M
26.58%-4.11M
229.03%1.89M
-3,153.80%-11.13M
-1,814.98%-9.12M
-Other impairment is provision
1.67%-11.09M
-5.77%-15.78M
7.30%-3.81M
-346.42%-4.66M
-1.33%-11.28M
-63.53%-14.92M
26.58%-4.11M
229.03%1.89M
-3,153.80%-11.13M
-1,814.98%-9.12M
Special items of operating profit
-27.98%68.67M
87.59%66.48M
-27.46%35.95M
2.19%11.78M
-55.96%95.35M
32.59%35.44M
12.83%49.56M
55.95%11.53M
82.02%216.54M
43.26%26.73M
Operating profit
6.20%-1.4B
2.21%-1.01B
-7.35%-748.59M
-1.58%-334.24M
-50.00%-1.49B
-40.94%-1.03B
-43.21%-697.37M
-13.06%-329.03M
-452.32%-992.07M
-5.41%-730.19M
Financing cost
-213.45%-72.38M
-1,239.27%-49.5M
-431.38%-31.87M
-256.14%-10.71M
-241.73%-23.09M
-91.90%4.34M
-175.72%-6M
-17.79%6.86M
-26.94%-6.76M
128.81%53.61M
Share of profits of associates
-131.11%-104K
----
----
----
---45K
----
----
----
----
----
Adjustment items of  earning before tax
----
-169.36%-15.56M
----
-147.00%-3.97M
----
50.34%-5.78M
----
61.33%-1.61M
----
38.68%-11.64M
Earning before tax
2.84%-1.47B
-3.96%-1.07B
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
After-tax profit from continuing operations
2.84%-1.47B
-3.96%-1.07B
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
Earning after tax
2.84%-1.47B
-3.96%-1.07B
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
Profit attributable to shareholders
2.84%-1.47B
-3.96%-1.07B
-10.96%-780.46M
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
Basic earnings per share
2.50%-2.73
-4.19%-1.99
-11.54%-1.45
-8.33%-0.65
-48.94%-2.8
-44.70%-1.91
-35.42%-1.3
-1.69%-0.6
-429.82%-1.88
6.38%-1.32
Diluted earnings per share
2.50%-2.73
-4.19%-1.99
-11.54%-1.45
-8.33%-0.65
-48.94%-2.8
-44.70%-1.91
-35.42%-1.3
-1.69%-0.6
-429.82%-1.88
6.38%-1.32
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
Audit Opinions
--
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
--
--
--
--
Ernst & Young
--
--
--
Ernst & Young
--
(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022
Turnover 58.92%1.71B57.10%1.21B76.50%739.66M96.41%330.43M40.16%1.08B35.08%769.47M20.15%419.07M12.06%168.24M-46.08%767.78M397.47%569.64M
Operating income 58.92%1.71B57.10%1.21B76.50%739.66M96.41%330.43M40.16%1.08B35.08%769.47M20.15%419.07M12.06%168.24M-46.08%767.78M397.47%569.64M
Cost of sales -35.42%-342.8M-----64.89%-169.27M----6.22%-253.14M----38.72%-102.66M-----301.92%-269.94M----
Operating expenses -35.42%-342.8M-37.65%-244.74M-64.89%-169.27M-196.17%-74.36M6.22%-253.14M20.47%-177.8M38.72%-102.66M74.25%-25.11M-301.92%-269.94M-2,079.96%-223.57M
Gross profit 66.14%1.37B62.95%964.13M80.26%570.39M78.91%256.08M65.31%822.99M70.97%591.67M74.55%316.42M171.98%143.13M-63.31%497.84M231.95%346.06M
Selling expenses -22.39%-948.76M-15.36%-622.7M-11.28%-389.67M-18.81%-187.5M-75.90%-775.19M-94.41%-539.79M-133.51%-350.17M-95.36%-157.82M-67.59%-440.7M-115.68%-277.66M
Administrative expenses -5.93%-332.28M3.39%-234.62M7.94%-155.22M5.70%-74.26M-15.09%-313.67M-51.17%-242.87M-57.70%-168.61M-60.52%-78.75M-23.97%-272.54M-0.86%-160.66M
Research and development expenses -17.87%-1.54B-34.43%-1.15B-49.18%-806.23M-32.62%-331.18M-33.01%-1.31B-29.50%-857.98M-20.19%-540.45M-14.46%-249.72M-38.13%-982.08M-26.29%-662.54M
Profit from asset sales ------88.36K-----------------------------3.02%15.5K
Revaluation surplus -----86.10%718.29K-----101.81%-49.46K-----55.15%5.17M------2.73M------11.53M
-Changes in the fair value of other assets -----86.10%718.29K-----101.81%-49.46K-----55.15%5.17M------2.73M------11.53M
Impairment and provision 1.67%-11.09M-5.77%-15.78M7.30%-3.81M-346.42%-4.66M-1.33%-11.28M-63.53%-14.92M26.58%-4.11M229.03%1.89M-3,153.80%-11.13M-1,814.98%-9.12M
-Other impairment is provision 1.67%-11.09M-5.77%-15.78M7.30%-3.81M-346.42%-4.66M-1.33%-11.28M-63.53%-14.92M26.58%-4.11M229.03%1.89M-3,153.80%-11.13M-1,814.98%-9.12M
Special items of operating profit -27.98%68.67M87.59%66.48M-27.46%35.95M2.19%11.78M-55.96%95.35M32.59%35.44M12.83%49.56M55.95%11.53M82.02%216.54M43.26%26.73M
Operating profit 6.20%-1.4B2.21%-1.01B-7.35%-748.59M-1.58%-334.24M-50.00%-1.49B-40.94%-1.03B-43.21%-697.37M-13.06%-329.03M-452.32%-992.07M-5.41%-730.19M
Financing cost -213.45%-72.38M-1,239.27%-49.5M-431.38%-31.87M-256.14%-10.71M-241.73%-23.09M-91.90%4.34M-175.72%-6M-17.79%6.86M-26.94%-6.76M128.81%53.61M
Share of profits of associates -131.11%-104K---------------45K--------------------
Adjustment items of  earning before tax -----169.36%-15.56M-----147.00%-3.97M----50.34%-5.78M----61.33%-1.61M----38.68%-11.64M
Earning before tax 2.84%-1.47B-3.96%-1.07B-10.96%-780.46M-7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M
After-tax profit from continuing operations 2.84%-1.47B-3.96%-1.07B-10.96%-780.46M-7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M
Earning after tax 2.84%-1.47B-3.96%-1.07B-10.96%-780.46M-7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M
Profit attributable to shareholders 2.84%-1.47B-3.96%-1.07B-10.96%-780.46M-7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M
Basic earnings per share 2.50%-2.73-4.19%-1.99-11.54%-1.45-8.33%-0.65-48.94%-2.8-44.70%-1.91-35.42%-1.3-1.69%-0.6-429.82%-1.886.38%-1.32
Diluted earnings per share 2.50%-2.73-4.19%-1.99-11.54%-1.45-8.33%-0.65-48.94%-2.8-44.70%-1.91-35.42%-1.3-1.69%-0.6-429.82%-1.886.38%-1.32
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)
Audit Opinions --------Unqualified Opinion------Unqualified Opinion--
Auditor --------Ernst & Young------Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Crypto ETF HK Crypto ETF

An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data. An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data.